Join the Future of Gene Editing: A Transformative Webinar on Recombinases
Upcoming Event Details
Mark your calendars! On Wednesday, September 24th, 2025, from 11:00 AM to 12:00 PM ET, a live webinar will explore the groundbreaking advancements in gene editing technology. Attendees will also have access to an on-demand recording, ensuring that everyone has a chance to engage with this vital conversation.
The Importance of Gene Editing
As we venture deeper into the 21st century, the therapeutic landscape is rapidly evolving, with gene editing standing at the forefront. The future of this field hinges on the development of tools that are not just effective but also programmable, scalable, and adaptable to treat a variety of diseases. Recombinases—a class of enzymes that facilitate genetic recombination—are emerging as a revolutionary solution in this space.
Overcoming Challenges in Recombinase Optimization
While the promise of recombinases is immense, optimizing their performance poses significant challenges. This isn’t merely about tweaking biological components; it requires a sophisticated blend of experimental techniques and computational advancements. This is where SeamlessTx enters the picture. Their unique platform integrates substantial directed evolution efforts and machine learning (ML) models to predict the activity and specificity of recombinant variants.
Meet SeamlessTx and Their Innovative Approach
Founded with a vision to push the boundaries of gene editing, SeamlessTx is making significant strides in optimizing recombinase performance. At the heart of this initiative is their ability to quickly validate predicted variants using Twist Gene Fragments—a feature that positions them at the cutting edge of recombinant technology. This combination of experimental rigor and computational foresight allows them to refine and accelerate the evolution of recombinant variants effectively.
Insights from Felix Lansing, PhD
In this webinar, Felix Lansing, Co-founder and Chief Technology Officer of SeamlessTx, will dive into the exciting data-driven approach his team employs to generate high-performance recombinases. His discussion will center around how these innovations are not only reshaping gene editing techniques but also expanding their therapeutic potential.
Key Topics of Discussion
Participants can look forward to engaging discussions centered around pivotal themes, including:
-
The Therapeutic Potential of Recombinases: Felix will outline how these enzymes can be harnessed to treat a range of diseases, offering hope for conditions that currently lack effective therapies.
-
Machine Learning Workflows: Attendees will gain insights into how ML is revolutionizing the process of evolving novel recombinases. The integration of cutting-edge technologies is streamlining workflows that were once cumbersome and time-consuming.
- Accelerated Variant Validation: A highlight of the session will focus on how SeamlessTx has successfully reduced their variant validation timelines to just 7-9 days. By leveraging Twist Gene Fragments, the company fuels an AI-driven engineering pipeline that not only speeds up the process but also enhances efficiency.
The Future is Bright
As we continue to grapple with complex health challenges, the developments in recombinase technology stand to reshape treatment strategies. By participating in this webinar, you’ll gain valuable knowledge about how these innovative approaches are set to transform the therapeutic landscape.
Don’t Miss Out!
Joining this conversation could offer deeper insights into the burgeoning field of gene editing, helping you remain at the cutting edge of healthcare technologies. Whether you’re a researcher, clinician, or simply someone passionate about biotechnology, this webinar is not to be missed!
How to Participate
Simply register for the webinar to ensure your spot. If you’re unable to attend live, the on-demand option allows for flexible viewing—so you can engage with this cutting-edge content at your convenience.
By discussing these essential topics, the webinar promises to illuminate the path forward in gene editing and recombinant technology. This is an opportunity to be part of a vibrant dialogue that stands to redefine how we approach medical challenges through innovation.